Portfolio composition
Equity holdings by reported value. Options and derivatives are not displayed in this view because filings may not provide enough contract-level detail.
This dashboard is based on public filings. 13F filings are delayed and show reported holdings, not every trade or exact execution price. Short positions, cash and some instruments may not be reflected. Reported value trends are not the same as realized investment performance.
Reported portfolio value
$4.02B
Equity holdings only
Number of holdings
26
Top holding
CME
$1.03B
Largest new position
CME
$1.03B
Largest increase
PL
$355.30M
Largest decrease
GLUE
$-424.46K
Last filing
May 8, 2026
Last update
May 8, 2026
Reported portfolio value ?
Earliest reported value
$365.05M
2013-12
Latest value
$4.02B
2026-03
Net reported value change
+$3.65B
+1,000.01%
Reported 13F equity value across filing periods. A drop can mean positions were sold, moved to cash, changed into instruments not shown on 13F, or simply were no longer reportable; it is not automatically an investment loss.
Holdings
| Ticker | Company | Shares | Reported value | Weight | Avg. adj. ref. price ? | First adj. ref. price ? | Latest quote ? | Est. change ? | Change | First seen ? | Latest report |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CME | CME GROUP INC | 3,484,020 | $1.03B | 25.63% | $295.35 Mar 31, 2026 | $295.35 Mar 31, 2026 | $284.23 May 8, 2026 | -$38.76M -3.77% | new | Mar 31, 2026 Filed May 8, 2026 | May 8, 2026 Report Mar 31, 2026 |
| PL | PLANET LABS PBC | 35,248,893 | $985.21M | 24.53% | $8.19 Mar 31, 2026 | $6.15 Dec 31, 2021 | $37.25 May 8, 2026 | +$1.02B +354.59% | increased +10.35% shares | Dec 31, 2021 Filed Nov 15, 2022 | May 8, 2026 Report Mar 31, 2026 |
| ASTS | AST SPACEMOBILE INC | 8,943,486 | $741.15M | 18.46% | $22.74 Mar 31, 2026 | $22.74 Mar 31, 2025 | $67.80 May 8, 2026 | +$402.99M +198.15% | unchanged 0.00% shares | Mar 31, 2025 Filed May 2, 2025 | May 8, 2026 Report Mar 31, 2026 |
| RVMD | REVOLUTION MEDICINES INC | 3,292,525 | $320.20M | 7.97% | $28.69 Mar 31, 2026 | $28.68 Dec 31, 2023 | $142.79 May 8, 2026 | +$375.66M +397.67% | reduced -1.57% shares | Dec 31, 2023 Filed Feb 9, 2024 | May 8, 2026 Report Mar 31, 2026 |
| ARM | ARM HOLDINGS PLC | 1,960,784 | $296.63M | 7.39% | $53.52 Mar 31, 2026 | $53.52 Sep 30, 2023 | $216.36 May 8, 2026 | +$319.28M +304.25% | unchanged 0.00% shares | Sep 30, 2023 Filed Nov 13, 2023 | May 8, 2026 Report Mar 31, 2026 |
| FRSH | FRESHWORKS INC | 16,206,643 | $130.14M | 3.24% | $18.61 Mar 31, 2026 | $26.26 Dec 31, 2021 | $8.70 May 8, 2026 | -$160.57M -53.24% | unchanged 0.00% shares | Dec 31, 2021 Filed Nov 15, 2022 | May 8, 2026 Report Mar 31, 2026 |
| PATH | UIPATH INC | 7,034,337 | $78.08M | 1.94% | $67.93 Mar 31, 2026 | $67.93 Jun 30, 2021 | $10.45 May 8, 2026 | -$404.37M -84.62% | unchanged 0.00% shares | Jun 30, 2021 Filed Nov 15, 2022 | May 8, 2026 Report Mar 31, 2026 |
| TEM | TEMPUS AI INC | 1,551,102 | $70.14M | 1.75% | $35.00 Mar 31, 2026 | $35.00 Jun 30, 2024 | $48.42 May 8, 2026 | +$20.82M +38.34% | unchanged 0.00% shares | Jun 30, 2024 Filed Aug 2, 2024 | May 8, 2026 Report Mar 31, 2026 |
| PAYP | PAYPAY CORP | 3,125,000 | $66.69M | 1.66% | $21.34 Mar 31, 2026 | $21.34 Mar 31, 2026 | $20.13 May 8, 2026 | -$3.78M -5.67% | new | Mar 31, 2026 Filed May 8, 2026 | May 8, 2026 Report Mar 31, 2026 |
| GTLB | GITLAB INC | 2,724,712 | $58.96M | 1.47% | $54.98 Mar 31, 2026 | $53.14 Jun 30, 2022 | $25.09 May 8, 2026 | -$81.44M -54.36% | unchanged 0.00% shares | Jun 30, 2022 Filed Nov 15, 2022 | May 8, 2026 Report Mar 31, 2026 |
| PRME | PRIME MEDICINE INC | 16,562,498 | $57.64M | 1.44% | $15.16 Mar 31, 2026 | $18.58 Dec 31, 2022 | $3.13 May 8, 2026 | -$199.36M -79.39% | unchanged 0.00% shares | Dec 31, 2022 Filed Feb 14, 2023 | May 8, 2026 Report Mar 31, 2026 |
| LIFE | ETHOS TECHNOLOGIES INC | 3,770,156 | $42.11M | 1.05% | $11.17 Mar 31, 2026 | $11.17 Mar 31, 2026 | $30.25 May 8, 2026 | +$71.93M +170.81% | new | Mar 31, 2026 Filed May 8, 2026 | May 8, 2026 Report Mar 31, 2026 |
| MAZE | MAZE THERAPEUTICS INC | 1,388,583 | $41.45M | 1.03% | $11.01 Mar 31, 2026 | $11.01 Mar 31, 2025 | $25.74 May 8, 2026 | +$20.45M +133.74% | unchanged 0.00% shares | Mar 31, 2025 Filed May 2, 2025 | May 8, 2026 Report Mar 31, 2026 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 2,823,126 | $25.27M | 0.63% | $11.58 Mar 31, 2026 | $11.58 Sep 30, 2025 | $7.86 May 8, 2026 | -$10.50M -32.12% | unchanged 0.00% shares | Sep 30, 2025 Filed Nov 7, 2025 | May 8, 2026 Report Mar 31, 2026 |
| RLAY | RELAY THERAPEUTICS INC | 1,564,173 | $15.56M | 0.39% | $41.71 Mar 31, 2026 | $42.59 Sep 30, 2020 | $12.64 May 8, 2026 | -$45.47M -69.69% | reduced -0.29% shares | Sep 30, 2020 Filed Nov 15, 2022 | May 8, 2026 Report Mar 31, 2026 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 684,275 | $11.26M | 0.28% | $22.70 Mar 31, 2026 | $22.70 Jun 30, 2021 | $19.62 May 8, 2026 | -$2.11M -13.59% | reduced -8.14% shares | Jun 30, 2021 Filed Nov 15, 2022 | May 8, 2026 Report Mar 31, 2026 |
| VERA | VERA THERAPEUTICS INC | 241,264 | $9.71M | 0.24% | $13.26 Mar 31, 2026 | $13.26 Jun 30, 2021 | $36.20 May 8, 2026 | +$5.53M +172.96% | unchanged 0.00% shares | Jun 30, 2021 Filed Nov 15, 2022 | May 8, 2026 Report Mar 31, 2026 |
| SANA | SANA BIOTECHNOLOGY INC | 2,812,500 | $8.10M | 0.20% | $33.47 Mar 31, 2026 | $33.47 Mar 31, 2021 | $3.48 May 8, 2026 | -$84.35M -89.60% | unchanged 0.00% shares | Mar 31, 2021 Filed Nov 15, 2022 | May 8, 2026 Report Mar 31, 2026 |
| BEAM | BEAM THERAPEUTICS INC | 321,604 | $7.66M | 0.19% | $18.00 Mar 31, 2026 | $18.00 Mar 31, 2020 | $31.01 May 8, 2026 | +$4.18M +72.28% | unchanged 0.00% shares | Mar 31, 2020 Filed Nov 15, 2022 | May 8, 2026 Report Mar 31, 2026 |
| LYEL | LYELL IMMUNOPHARMA INC | 293,256 | $5.88M | 0.15% | $8.84 Mar 31, 2026 | $8.84 Jun 30, 2025 | $19.44 May 8, 2026 | +$3.11M +119.91% | unchanged 0.00% shares | Jun 30, 2025 Filed Aug 1, 2025 | May 8, 2026 Report Mar 31, 2026 |
| OSCR | OSCAR HEALTH INC | 481,988 | $5.53M | 0.14% | $26.88 Mar 31, 2026 | $26.88 Mar 31, 2021 | $20.58 May 8, 2026 | -$3.04M -23.43% | unchanged 0.00% shares | Mar 31, 2021 Filed Nov 15, 2022 | May 8, 2026 Report Mar 31, 2026 |
| FIG | FIGMA INC | 215,582 | $4.56M | 0.11% | $51.87 Mar 31, 2026 | $51.87 Sep 30, 2025 | $19.77 May 8, 2026 | -$6.92M -61.89% | unchanged 0.00% shares | Sep 30, 2025 Filed Nov 7, 2025 | May 8, 2026 Report Mar 31, 2026 |
| SPRO | SPERO THERAPEUTICS INC | 889,979 | $2.08M | 0.05% | $11.75 Mar 31, 2026 | $11.75 Dec 31, 2017 | $2.51 May 8, 2026 | -$8.22M -78.64% | unchanged 0.00% shares | Dec 31, 2017 Filed Nov 15, 2022 | May 8, 2026 Report Mar 31, 2026 |
| HYPR | HYPERFINE INC | 898,720 | $970.62K | 0.02% | $7.25 Mar 31, 2026 | $7.25 Dec 31, 2021 | $1.71 May 8, 2026 | -$4.98M -76.48% | unchanged 0.00% shares | Dec 31, 2021 Filed Nov 15, 2022 | May 8, 2026 Report Mar 31, 2026 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 698,262 | $963.60K | 0.02% | $26.79 Mar 31, 2026 | $26.79 Jun 30, 2018 | $1.62 May 8, 2026 | -$17.58M -93.97% | unchanged 0.00% shares | Jun 30, 2018 Filed Nov 15, 2022 | May 8, 2026 Report Mar 31, 2026 |
| TNYA | TENAYA THERAPEUTICS INC | 915,705 | $631.84K | 0.02% | $20.65 Mar 31, 2026 | $20.65 Sep 30, 2021 | $0.93 May 8, 2026 | -$18.06M -95.50% | unchanged 0.00% shares | Sep 30, 2021 Filed Nov 15, 2022 | May 8, 2026 Report Mar 31, 2026 |
Latest changes
These rows compare the latest parsed 13F snapshot with the prior one. A reported exit means the security no longer appears in the latest filing; it is not a realized loss. The same ticker can appear more than once when different CUSIPs or security classes are reported.
Reported additions
$1.49B
3 new / 1 increased
Reported reductions/exits
$75.41M
3 reduced / 6 exits
Net reported change
+$1.44B
Position value delta, not cash flow
| Action | Ticker / CUSIP | Company | Share delta | Reported value | Implied ref price ? | Report period |
|---|---|---|---|---|---|---|
| new | CME CUSIP 12572Q105 | CME GROUP INC | 3,484,020 | +$1.03B | $295.35 | Mar 31, 2026 Latest report |
| increased | PL CUSIP 72703X106 | PLANET LABS PBC | 3,306,252 +10.35% | +$355.30M | $107.46 | Mar 31, 2026 Latest report |
| unchanged | ASTS CUSIP 00217D100 | AST SPACEMOBILE INC | 0 0.00% | +$91.58M | N/A | Mar 31, 2026 Latest report |
| unchanged | ARM CUSIP 042068205 | ARM HOLDINGS PLC | 0 0.00% | +$82.29M | N/A | Mar 31, 2026 Latest report |
| reported exit | DXCM CUSIP 252131107 | DEXCOM INC | No longer reported was 1,036,937 shares | $68.82M previous reported value | $66.37 | Removed by Mar 31, 2026 Was reported Dec 31, 2025 |
| unchanged | FRSH CUSIP 358054104 | FRESHWORKS INC | 0 0.00% | -$68.39M | N/A | Mar 31, 2026 Latest report |
| new | PAYP CUSIP 70450C101 | PAYPAY CORP | 3,125,000 | +$66.69M | $21.34 | Mar 31, 2026 Latest report |
| reduced | RVMD CUSIP 76155X100 | REVOLUTION MEDICINES INC | -52,577 -1.57% | +$53.76M reported reduction | $1,022.51 | Mar 31, 2026 Latest report |
| unchanged | GTLB CUSIP 37637K108 | GITLAB INC | 0 0.00% | -$43.30M | N/A | Mar 31, 2026 Latest report |
| new | LIFE CUSIP 29765A101 | ETHOS TECHNOLOGIES INC | 3,770,156 | +$42.11M | $11.17 | Mar 31, 2026 Latest report |
| unchanged | PATH CUSIP 90364P105 | UIPATH INC | 0 0.00% | -$37.21M | N/A | Mar 31, 2026 Latest report |
| unchanged | TEM CUSIP 88023B103 | TEMPUS AI INC | 0 0.00% | -$21.45M | N/A | Mar 31, 2026 Latest report |
Options and derivatives are not displayed in these tables because public filings may not provide enough contract-level data to calculate accurate option returns.